Genetic Analysis AS (XSAT:GEAN)
0.7000
+0.0400 (6.06%)
At close: Feb 25, 2026
Genetic Analysis AS Market Cap
Genetic Analysis AS has a market cap or net worth of 45.73 million as of February 26, 2026. Its market cap has increased by 97.80% in one year.
Market Cap
45.73M
Enterprise Value
35.63M
Revenue
20.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.70
Market Cap Chart
Since October 1, 2021, Genetic Analysis AS's market cap has decreased from 235.48M to 45.73M, a decrease of -80.58%. That is a compound annual growth rate of -31.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 45.73M | 3.26% |
| Dec 30, 2025 | 44.29M | 81.07% |
| Dec 30, 2024 | 24.46M | -31.37% |
| Dec 29, 2023 | 35.64M | -34.69% |
| Dec 30, 2022 | 54.57M | -66.71% |
| Dec 30, 2021 | 163.91M | -30.39% |
| Oct 1, 2021 | 235.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BiBBInstruments AB | 85.96M |
| Smoltek Nanotech Holding AB | 80.82M |
| QBNK Holding AB | 65.33M |
| Redsense Medical AB | 59.69M |
| Sound Dimension AB | 54.08M |
| Touchtech AB | 44.01M |
| Photocat | 35.97M |
| Lightning Group AB | 33.85M |